Sten Wingren
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 30
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 6
-
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 10
- Co-authors
- Bo A. Nordenskjöld (23 shared papers)Olle Stål (20 shared papers)John M. Carstensen (18 shared papers)Pia Wegman (12 shared papers)Lambert K. Skoog (7 shared papers)Thomas Hatschek (7 shared papers)Lars Erik Rutqvist (5 shared papers)Elingarami Sauli (1 shared paper)
- Journals
- European Journal of Cancer (7 papers)Acta Oncologica (6 papers)British Journal of Cancer (6 papers)Breast Cancer Research and Treatment (5 papers)International Journal of Cancer (4 papers)
- Partner nations
- SwedenUnited StatesIreland
In The Last Decade
Sten Wingren
64 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Pharmacology 400
- Cancer Research 551
- Oncology 873
- Pathology and Forensic Medicine 344
- Genetics 536
Countries citing papers authored by Sten Wingren
This map shows the geographic impact of Sten Wingren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sten Wingren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sten Wingren more than expected).
Fields of papers citing papers by Sten Wingren
This network shows the impact of papers produced by Sten Wingren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sten Wingren. The network helps show where Sten Wingren may publish in the future.
Co-authors
The 25 scholars most cited alongside Sten Wingren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 241 | |
| 2 | 1992 | 200 | |
| 3 | 2005 | 195 | |
| 4 | 2013 | 144 | |
| 5 | Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. | 1999 | 115 |
| 6 | 1995 | 114 | |
| 7 | 1989 | 75 | |
| 8 | 1989 | 66 | |
| 9 | 1993 | 60 | |
| 10 | 2000 | 59 | |
| 11 | 1994 | 56 | |
| 12 | 2001 | 55 | |
| 13 | 2014 | 54 | |
| 14 | 2007 | 53 | |
| 15 | 2002 | 50 | |
| 16 | 2001 | 49 | |
| 17 | 2005 | 43 | |
| 18 | 1988 | 41 | |
| 19 | 1996 | 37 | |
| 20 | 1996 | 36 |
About Sten Wingren
Sten Wingren is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Genetics and Pharmacology, having authored 65 papers that have together received 2.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (13 papers), Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers), Cancer-related Molecular Pathways (9 papers), Genetic factors in colorectal cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Pharmacology (400 citations), Cancer Research (551 citations), Oncology (873 citations), Pathology and Forensic Medicine (344 citations) and Genetics (536 citations). Sten Wingren has collaborated with scholars based in Sweden, United States and Ireland. Frequent co-authors include Bo A. Nordenskjöld, Olle Stål, John M. Carstensen, Pia Wegman, Lambert K. Skoog, Thomas Hatschek, Lars Erik Rutqvist, Elingarami Sauli, Xiao‐Feng Sun and Peter Söderkvist. Their work appears in journals such as European Journal of Cancer, Acta Oncologica, British Journal of Cancer, Breast Cancer Research and Treatment and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.